Literature DB >> 9459447

CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95.

S R Jaffrey1, A M Snowman, M J Eliasson, N A Cohen, S H Snyder.   

Abstract

Nitric oxide (NO) produced by neuronal nitric oxide synthase (nNOS) is important for N-methyl-D-aspartate (NMDA) receptor-dependent neurotransmitter release, neurotoxicity, and cyclic GMP elevations. The coupling of NMDA receptor-mediated calcium influx and nNOS activation is postulated to be due to a physical coupling of the receptor and the enzyme by an intermediary adaptor protein, PSD95, through a unique PDZ-PDZ domain interaction between PSD95 and nNOS. Here, we report the identification of a novel nNOS-associated protein, CAPON, which is highly enriched in brain and has numerous colocalizations with nNOS. CAPON interacts with the nNOS PDZ domain through its C terminus. CAPON competes with PSD95 for interaction with nNOS, and overexpression of CAPON results in a loss of PSD95/nNOS complexes in transfected cells. CAPON may influence nNOS by regulating its ability to associate with PSD95/NMDA receptor complexes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459447     DOI: 10.1016/s0896-6273(00)80439-0

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  104 in total

Review 1.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Nitric oxide is an essential negative regulator of cell proliferation in Xenopus brain.

Authors:  N Peunova; V Scheinker; H Cline; G Enikolopov
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

3.  There's NO binding like NOS binding: protein-protein interactions in NO/cGMP signaling.

Authors:  Pavel I Nedvetsky; William C Sessa; Harald H H W Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

4.  Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Authors:  Kristin K Nicodemus; Amanda J Law; Eugenia Radulescu; Augustin Luna; Bhaskar Kolachana; Radhakrishna Vakkalanka; Dan Rujescu; Ina Giegling; Richard E Straub; Kate McGee; Bert Gold; Michael Dean; Pierandrea Muglia; Joseph H Callicott; Hao-Yang Tan; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2010-10

Review 5.  Research progress on neurobiology of neuronal nitric oxide synthase.

Authors:  Chun-Xia Luo; Dong-Ya Zhu
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

6.  A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes.

Authors:  J Lu; C Hu; W Hu; R Zhang; C Wang; W Qin; W Yu; K Xiang; W Jia
Journal:  Diabet Med       Date:  2010-09       Impact factor: 4.359

7.  Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II.

Authors:  Neeru M Sharma; Hong Zheng; Parmender P Mehta; Yi-Fan Li; Kaushik P Patel
Journal:  Cardiovasc Res       Date:  2011-08-10       Impact factor: 10.787

Review 8.  Psychiatric behaviors associated with cytoskeletal defects in radial neuronal migration.

Authors:  Toshifumi Fukuda; Shigeru Yanagi
Journal:  Cell Mol Life Sci       Date:  2017-05-17       Impact factor: 9.261

9.  Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate.

Authors:  Barbara Kremeyer; Jenny García; Hanna Kymäläinen; Naomi Wratten; Gabriel Restrepo; Carlos Palacio; Ana Lucía Miranda; Carlos López; Margarita Restrepo; Gabriel Bedoya; Linda M Brzustowicz; Jorge Ospina-Duque; María Patricia Arbeláez; Andrés Ruiz-Linares
Journal:  Hum Hered       Date:  2008-12-15       Impact factor: 0.444

10.  NOS1AP Functionally Associates with YAP To Regulate Hippo Signaling.

Authors:  Leanne Clattenburg; Michael Wigerius; Jiansong Qi; Jan K Rainey; Jillian L Rourke; Shanmugam Muruganandan; Christopher J Sinal; James P Fawcett
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.